(Q44333895)

2 December 2017

title

The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

21 October 2022

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

21 October 2022

author name string

M. Trampus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1647961

21 October 2022

E. Ongini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1647961

21 October 2022

K. Varani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1647961

21 October 2022

P. A. Borea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1647961

21 October 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

2 December 2017

26 February 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1647961

full work available at URL

21 October 2022

https://api.elsevier.com/content/article/PII:001429999190118A?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

https://api.elsevier.com/content/article/PII:001429999190118A?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

European Journal of Pharmacology

21 October 2022

published in

1 reference

2 December 2017

volume

194

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

17-23

1 reference

Stimulation of Dopamine Synthesis in Caudate Nucleus by Intrastriatal Enkephalins and Antagonism by Naloxone

2 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11)

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Protein measurement with the Folin phenol reagent

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Regional distribution of a high-affinity enkephalin-degrading peptidase (‘enkephalinase’) and effects of lesions suggest localization in the vicinity of opiate receptors in brain

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Classification of opioid receptors

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Enkephalin receptors on dopaminergic neurones in rat striatum

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

21 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors

21 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats

21 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor

21 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Decrease in delta-opioid receptor density in rat brain after chronic [D-Ala2,D-Leu5]enkephalin treatment

21 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat

21 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Stimulation of dopamine synthesis and release by morphine and D-Ala2-D-Leu5-enkephalin in the mouse striatum

21 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitors

21 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord.

21 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90118-A

21 October 2022

Identifiers

1 reference

2 December 2017

1 reference